SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-008153
Filing Date
2022-02-09
Accepted
2022-02-09 17:48:19
Documents
2
Period of Report
2022-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5487
2 POA DOCUMENT poa.txt EX-24 3567
  Complete submission text file 0001209191-22-008153.txt   10539
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Issuer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O KURA ONCOLOGY, INC. 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address
DOYLE THOMAS JAMES (Reporting) CIK: 0001910331 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37620 | Film No.: 22608549